| Database ID | Agent | Target | Cancer Type | Detail |
| DB00766 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | lung cancer | view |
| DB00767 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00768 | Vorinostat and erlotinib | Histone deacetylase 1 | non small cell lung cancer | view |
| DB00769 | dacomitinib erlotinib | NA | non small cell lung cancer | view |
| DB00770 | PF3512676 | tolllike receptor | non small cell lung cancer | view |
| DB00771 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | non small cell lung cancer | view |
| DB00772 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | non small cell lung cancer | view |
| DB00773 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00774 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00775 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00776 | Tivantinib (ARQ 197) and Erlotinib | NA | non small cell lung cancer | view |
| DB00777 | apricoxib | Prostaglandin G/H synthase 2 | non small cell lung cancer | view |
| DB00778 | ganetespib | VEGFR, cMET, human epidermal growth factor receptor 2, IGFIR, EGFR, and other Hsp90 client proteins | non small cell lung cancer | view |
| DB00779 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00780 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |